Skip to main content

JDRF has now rebranded to Breakthrough T1D.
Our name has changed, our mission has not.

Research news

Top 10 research priorities for adults living with type 1 diabetes

A study we helped conduct, which has just been published, reveals the most important unanswered questions about type 1 diabetes, based on the priorities of adults in the United Kingdom and Ireland. This will help guide future research to focus on what matters most to people living with the condition.
Breakthrough T1D profile picture
Breakthrough T1D staff 3 September 2024

Five people in an office around a table in discussion about work

A new research paper titled “The Top Ten Priorities in Adults Living with Type 1 Diabetes in Ireland and the United Kingdom – A James Lind Alliance Priority Setting Partnership” has been published in Diabetic Medicine. It highlights the most pressing concerns and priorities of adults living with type 1 diabetes.

Person-centred care and research

The study was conducted through a collaborative effort by people living with type 1 diabetes, their families, diabetes charities like us and clinicians across Ireland and the United Kingdom, using the James Lind Alliance (JLA) Priority Setting Partnership (PSP) approach. JLA PSPs bring patients, carers, clinicians and charities together to establish the real concerns and priorities of people directly impacted by a condition, ensuring that future research focuses on what is most important to them. This work represents a significant step forward in person-centred care and research, ensuring that the voices of people living with type 1 diabetes are heard and acted upon.

The 10 research priorities reflect the varied issues that are most important to people affected by type 1 diabetes. Their purpose is to help funding organisations, like ourselves, and researchers ensure they address the key concerns of people living with type 1 in their future work.

Dr Christine Newman, the lead author of the study, said:

“This study is a powerful example of how Public and Patient Involvement can shape the future of healthcare. This work highlights the real-world challenges and unmet needs of adults living with type 1 diabetes. By focusing on these top 10 priorities, we can ensure that future research and healthcare services are aligned with what truly matters to those affected by the condition.”

What are the top 10 research priorities?

The priorities cover a range of topics including type 1 technology, diabetes distress, ageing, insulin resistance and access to new treatments.

  1. The top priority covers using artificial intelligence and new faster insulins to turn hybrid closed loop technology into fully closed loop systems where no input is needed from the user.
  2. The second most important priority encourages researchers to consider whether time in range is a better measurement to use than HbA1c, which is an average reading of blood glucose over three months.
  3. The third sees a focus on women’s health, asking the impact of female hormonal changes on blood glucose levels and how to best manage these.

You can find the full list of research questions in the paper published in Diabetic Medicine.

How were the research priorities decided?

The Priority Setting Partnership designed and shared a survey which asked people affected by type 1 to list three questions about type 1 diabetes. Over a thousand people responded to the first survey, most of whom are adults living with type 1 diabetes, as well as some healthcare professionals and family members of people living with type 1.

The Priority Setting Partnership members then sent out a second survey asking participants to rank 65 research questions from the first survey responses in order of importance. The top 19 questions were taken to a final workshop, held over two days, where the top 10 priorities were finalised and ranked.

JDRF involvement

Three members of JDRF UK were part of the Priority Setting Partnership that facilitated the focus groups to discuss and help narrow down the key priorities for people living with type 1.

Rachel Connor, Director of Research Partnerships at JDRF UK and co-author of the new research paper, said:

“Research MUST reflect the needs of people who live with type 1 diabetes. Over a thousand people living with type 1 and their loved ones participated in this exercise and by doing so they provided a unique picture of the challenges they face and their hopes for managing the condition in the future. These 10 priorities can guide researchers and research funders alike in focusing on the areas of research that will deliver the impact that people with type 1 diabetes want to see in their lives.”

Changes in the last decade

The current priorities are an updated version of those set through a similar study in 2011, but which didn’t include people in Ireland. Over the past decade, we have used these priorities, which focused on diabetes technology, mental health, diabetes complications, and hypoglycaemia, to guide our research and advocacy work. The top three research questions from 2011 have now been addressed, with continuous glucose monitoring (CGM) and HCL technology available on the NHS for most people living with type 1 in England, Scotland and Wales.

Our continuous funding to develop type 1 technology and secure access on the NHS has only been possible thanks to our generous supporters. We will now use these 10 new research priorities to ensure the research we fund continues to meet the changing needs of people living with type 1 diabetes.

More research news

Read more
Scientist researcher woman in white coat using microscope in laboratory
Research
1 July 2025

New trial results show potential protection against kidney damage in young adults  

A recent study has shown that a treatment currently used for type 2 diabetes could be used to help prevent kidney damage in young adults with type 1

Read more
A woman researcher at work in a lab
Research
24 June 2025

Six-month clinical data shows engineered islets can exist without immunosuppression

New data from Sana Biotechnology, in collaboration with Uppsala University Hospital in Sweden, shows that six months post-transplant, one person with type 1 diabetes (T1D) is successfully producing insulin and does not require immunosuppression.

Read more
Vertex Pharmaceuticals logo graphic
Research
23 June 2025

Vertex trial of Zimislecel cellular therapy enables ten of 12 participants to remain insulin independent

US-based company Vertex have published promising figures from their cell therapy trial, showing advancements in stem cell research.

Read more
Two older men at home reading type 1 diabetes information booklets.
Research
17 June 2025

Healthcare systems unprepared for rising number of older adults with T1D

We're calling for urgent reform as new report reveals older people with T1D are systematically failed by health and social care services.

Connect with us on social